Table 3 Comparison of echocardiographic parameters at baseline and after 3 months of treatment for the study groups.
Variables | TMZ group (n = 30) | Placebo group (n = 29) | p-value | |
LVEDD (mm) | Baseline | 48.73 ± 3.81 | 49.24 ± 5.65 | 0.686a |
After 3 months | 49.36 ± 3.56 | 49.52 ± 3.69 | 0.874a | |
% change | 1.54 ± 6.78 | 1.15 ± 7.29 | 0.83a | |
LVESD (mm) | Baseline | 30.7 ± 3.16 | 30.89 ± 4.78 | 0.853a |
After 3 months | 30.53 ± 3 | 31.34 ± 4.02 | 0.382a | |
% change | −0.01 ± 10.14 | 2.06 ± 8.9 | 0.408a | |
LAD (mm) | Baseline | 40.3 ± 5.07 | 39.48 ± 4.03 | 0.497a |
After 3 months | 39 ± 4.99 | 40.07 ± 4.48 | 0.391a | |
% change | −2.65 ± 11.32 | 1.91 ± 10.66 | 0.117a | |
RWT | Baseline | 0.39 ± 0.04 | 0.401 ± 0.04 | 0.552a |
After 3 months | 0.39 ± 0.05 | 0.41 ± 0.04 | 0.263a | |
% change | −0.09 ± 10.32 | 2.86 ± 15.93 | 0.404a | |
LVMI (g/m2) | Baseline | 85.94 ± 14.77 | 86.68 ± 18.96 | 0.868a |
After 3 months | 88.52 ± 14.97 | 91.18 ± 20.18 | 0.567a | |
% change | 5.19 ± 22.99 | 6.44 ± 18.45 | 0.819a | |
LVEDVI (ml/m2) | Baseline | 39.88 ± 7.49 | 41.79 ± 9.38 | 0.392a |
After 3 months | 38.4 ± 6.8 | 38.51 ± 8.34 | 0.957a | |
% change | −2.48 ± 14.59 | −6.39 ± 14.42 | 0.304a | |
LVESVI (ml/m2) | Baseline | 15.44 ± 3.47 | 16.71 ± 4.62 | 0.237a |
After 3 months | 14.92 ± 3.64 | 15.83 ± 4.29 | 0.382a | |
% change | −1.56 ± 22.14 | −2.58 ± 20.87 | 0.856a | |
EF % | Baseline | 61.36 ± 5.02 | 61.55 ± 4.06 | 0.877 a |
After 3 months | 61.83 ± 4.89 | 59.41 ± 3.41 | 0.032*a | |
% change | 1.59 ± 13.12 | −3.28 ± 5.26 | 0.068a | |
E (cm/s) | Baseline | 69.86 ± 14.67 | 70.24 ± 17.37 | 0.929 a |
After 3 months | 73.76 ± 16.25 | 72.62 ± 17.86 | 0.797a | |
% change | 6.75 ± 17.64 | 5.2 ± 21.59 | 0.763a | |
A (cm/s) | Baseline | 87.66 ± 13.74 | 79 ± 12.45 | 0.014*a |
After 3 months | 85.26 ± 14.27 | 78.83 ± 13.63 | 0.082a | |
% change | −2.22 ± 10.84 | 0.04 ± 9.64 | 0.402a | |
E/A ratio | Baseline | 0.79 ± 0.13 | 0.89 ± 0.19 | 0.035*a |
After 3 months | 0.87 ± 0.16 | 0.93 ± 0.2 | 0.237a | |
% change | 9.15 ± 13.29 | 5.04 ± 18.47 | 0.329a | |
DT (ms) | Baseline | 190.7 ± 35.82 | 193.41 ± 43.31 | 0.794a |
After 3 months | 194.76 ± 34.37 | 198.03 ± 39.31 | 0.737a | |
% change | 4.37 ± 22.12 | 2.39 ± 32.91 | 0.786a | |
LAVI (ml/m2) | Baseline | 31.54 ± 7.36 | 30.48 ± 6.28 | 0.555a |
After 3 months | 28.77 ± 5.55 | 30.39 ± 6.53 | 0.307a | |
% change | −6.99 ± 13.68 | 0.66 ± 13.39 | 0.034*a | |
Septal e’ (cm/s) | Baseline | 6.43 ± 1.33 | 6.82 ± 1.58 | 0.304a |
After 3 months | 7.13 ± 1.36 | 6.62 ± 1.42 | 0.162a | |
% change | 13.06 ± 19.92 | −0.96 ± 18.35 | 0.007*a | |
Lateral e’ (cm/s) | Baseline | 8.96 ± 2.44 | 8.34 ± 1.95 | 0.285a |
After 3 months | 9.2 ± 2.01 | 8 ± 1.79 | 0.019*a | |
% change | 6.69 ± 23.45 | −2.09 ± 19.63 | 0.124a | |
Average e’ (cm/s) | Baseline | 7.7 ± 1.71 | 7.58 ± 1.63 | 0.795a |
After 3 months | 8.16 ± 1.53 | 7.29 ± 1.45 | 0.028*a | |
% change | 8.46 ± 18.64 | −2.49 ± 14.52 | 0.015*a | |
Average E/ e’ ratio | Baseline | 9.51 ± 3.21 | 9.48 ± 2.37 | 0.969 a |
After 3 months | 9.23 ± 2.34 | 10.19 ± 2.9 | 0.167a | |
% change | 0.03 ± 17.96 | 9.39 ± 23.91 | 0.094a | |
LVGLS % | Baseline | −17.01 ± 1.98 | −17.27 ± 3.45 | 0.717a |
After 3 months | −18.02 ± 2.35 | −16.65 ± 3.02 | 0.056a | |
% change | 6.66 ± 13.88 | −2.79 ± 9.64 | 0.004*a |